Showing results (71-80 of 456) with videos related to
Sort By:
Pageof 46
Diabetes, Obesity & Metabolism|January 25, 2012
Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitusG Luippold, T Klein, M Mark, et al.Archives of Disease in Childhood|September 1, 1979
Folate nutrition and growth in infancyY Matoth, I Zehavi, E Topper, et al.The Journal of Foot Surgery|November 1, 1985
Carbon dioxide laser methodology for ablation of plantar verrucaeM Borovoy, J T Klein, T A FullerExperientia|October 15, 1978
Folic acid levels in blood and seminal plasma of normo- and oligospermic patients prior and following folic acid treatmentB Landau, R Singer, T Klein, et al.Infection and Immunity|January 1, 1984
Immunostimulation by Legionella pneumophila antigen preparations in vivo and in vitroH Friedman, R Widen, T Klein, et al.Science and Technology of Advanced Materials|November 24, 2016
Creep behavior and in-depth microstructural characterization of dissimilar jointsF Kauffmann, T Klein, A Klenk, et al.Molecular Pharmacology|May 1, 1985
A quantitative structure-activity relationship and molecular graphics study of carbonic anhydrase inhibitorsC Hansch, J McClarin, T Klein, et al.Gynecologic and Obstetric Investigation|January 1, 1994
Natural killer cell activity in early human pregnancyM Opsahl, K Hansen, T Klein, et al.Seminars in Respiratory Infections|June 27, 1998
Immunologic response and pathophysiology of Legionella infectionH Friedman, Y Yamamoto, C Newton, et al.Molecular Pharmacology|April 4, 1998
On the induction of cyclooxygenase-2, inducible nitric oxide synthase and soluble phospholipase A2 in rat mesangial cells by a nonsteroidal anti-inflammatory drug: the role of cyclic AMPT Klein, V Ullrich, J Pfeilschifter, et al.Pageof 46